Quil A-based candidate measles vaccines have been shown to be immunogenic and protective in cotton rats and macaques. Here we studied the longevity of protective VN antibody levels induced in macaques with one dose of measles virus (MV) iscom. Inactivated MV adjuvanted with iscom-matrix or with purified Quillaja saponin QA-22 were also tested. All animals developed high levels of VN antibody and MV-specific IFNγ-producing cells. Especially the high VN antibody levels induced by the latter two preparations showed virtually no decrease during the 2-year follow-up. These highly promising candidate MV vaccines should now be tested in infant macaques in the presence or absence of passively transferred and/or maternally derived VN antibodies. In addition, the immunopathological safety of the constructs should be evaluated in the atypical measles model in rhesus macaques.

Additional Metadata
Persistent URL dx.doi.org/10.1016/S0264-410X(02)00453-X, hdl.handle.net/1765/39709
Journal Vaccine
Citation
Stittelaar, K.J, Vos, H.W, van Amerongen, G, Kersten, G.F.A, Osterhaus, A.D.M.E, & de Swart, R.L. (2002). Longevity of neutralizing antibody levels in macaques vaccinated with Quil A-adjuvanted measles vaccine candidates. Vaccine, 21(3-4), 155–157. doi:10.1016/S0264-410X(02)00453-X